Press Releases

Date Title and Summary
Toggle Summary Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems SUNNYVALE, Calif. , Aug. 17, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) and the Summit Cancer
Toggle Summary Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
SUNNYVALE, Calif. , Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m.
Toggle Summary First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting
SUNNYVALE, Calif. , Aug. 4, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were presented at the 59th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in
Toggle Summary Accuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System
iDMS System Allows Seamless Integration between Accuray Radixact™, TomoTherapy® and CyberKnife® Systems and Treatment Planning Systems SUNNYVALE, Calif. , July 31, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has received 510(k) clearance from the U.S.
Toggle Summary Accuray Enhances Capital Structure Through Convertible Debt Transactions
­Transactions Facilitate Reduction of Short-term Debt and Potential Dilution to Shareholders SUNNYVALE, Calif. , July 28, 2017 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) has entered into privately negotiated agreements with a limited number of existing holders of the company's outstanding
Toggle Summary New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific Survival Rate and Post-Treatment Salivary Function SUNNYVALE, Calif.
Toggle Summary Accuray Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results
Q4 Revenue Expected to be Approximately $111.5-$112 Million and Q4 Gross Orders Expected to be Approximately $86 Million; Accuray Expects to Finish Fiscal Year with Approximately $108 Million in Cash, Cash Equivalents & Investments Preliminary Revenue and Product Order Results for Fourth
Toggle Summary Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife® and Radixact™ Systems
Leading Hospital will be the First in the Middle East to Offer Patients Precise Treatments with the Latest Generations of Both Systems SUNNYVALE, Calif. , July 11, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding access to its products in the Middle
Toggle Summary Montefiore is First in NY Metropolitan Area to Treat Cancer Patients with Accuray Radixact™ System
Cutting-Edge Radiation Therapy System Dramatically Improves Precision, Efficiency and Safety, While Minimizing Side Effects SUNNYVALE, Calif. and NEW YORK , June 27, 2017 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) and Montefiore Einstein Center for Cancer Care (MECCC), part of the
Toggle Summary IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact™ System
The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray SUNNYVALE, Calif. , June 20, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the University Cancer Institute of Toulouse